B
Amgen Inc. AMGN
$269.12 -$2.19-0.81%
Recommendation
Buy
Prev Close
$271.31
Volume
2,608,218
Avg Vol (90D)
2,443,455
Market Cap
$145.20B
Dividend & Yield
$8.52(3.14%)
52-Week Range
$211.71 - $288.46
P/E (TTM)
19.29
EPS (TTM)
$14.06
My Lists My Alerts
Report
Rating
Reward
B
Good
Risk
C
Fair
Rating Factors
Growth Index
Good
Efficiency Index
Excellent
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
Good
Headlines
4,288 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Guidance Capital Inc.
12/8/2023 - Ticker Report
AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
12/8/2023 - PR Newswire
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Edwards Lifesciences (EW)
12/8/2023 - TipRanks Financial Blog
First Foundation Advisors Trims Position in Amgen Inc. (NASDAQ:AMGN)
12/7/2023 - Ticker Report
Aristotle Capital Management LLC Decreases Position in Amgen Inc. (NASDAQ:AMGN)
12/6/2023 - Ticker Report
State Street Corp Cuts Stake in Amgen Inc. (NASDAQ:AMGN)
12/6/2023 - Ticker Report
145,166 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by UniSuper Management Pty Ltd
12/6/2023 - Ticker Report
Snowden Capital Advisors LLC Raises Position in Amgen Inc. (NASDAQ:AMGN)
12/6/2023 - Ticker Report
Mogy Joel R Investment Counsel Inc. Purchases 1,000 Shares of Amgen Inc. (NASDAQ:AMGN)
12/5/2023 - Ticker Report
Treasurer of the State of North Carolina Sells 1,747 Shares of Amgen Inc. (NASDAQ:AMGN)
12/5/2023 - Ticker Report
Biogen vet's new startup raises nine-figure round
12/5/2023 - Bizjournals.com - Health Care News
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Lbp Am Sa
12/5/2023 - Ticker Report
Nancy A. Grygiel Sells 2,096 Shares of Amgen Inc. (NASDAQ:AMGN) Stock
12/5/2023 - Zolmax
Mendel Money Management Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
12/4/2023 - Ticker Report
Biogen vet's new startup raises nine-figure round, moves to Watertown
12/4/2023 - Bizjournals.com - Health Care News
Amgen: Relative Valuation Remains Unattractive
12/3/2023 - GuruFocus
Lcnb Corp Purchases 427 Shares of Amgen Inc. (NASDAQ:AMGN)
12/3/2023 - Ticker Report
Amgen (NASDAQ:AMGN) Receives Buy Rating from Truist Financial
12/3/2023 - Ticker Report
Amgen Inc. (NASDAQ:AMGN) Holdings Increased by SageView Advisory Group LLC
12/1/2023 - Ticker Report
Bryn Mawr Capital Management LLC Sells 655 Shares of Amgen Inc. (NASDAQ:AMGN)
12/1/2023 - Ticker Report
Looking Into Amgen's Recent Short Interest
11/30/2023 - Benzinga
Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?
11/30/2023 - Zacks Investment Research
The Zacks Analyst Blog Highlights McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software
11/30/2023 - Zacks Investment Research
Amgen (NASDAQ:AMGN) Given Buy Rating at Truist Financial
11/30/2023 - Zolmax
Truist Financial Sticks to Their Buy Rating for Amgen (AMGN)
11/30/2023 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$26.83B
EBITDA (TTM)
$13.29B
EBIT (TTM)
$9.68B
Net Income (TTM)
$7.57B
Balance Sheet
Total Assets (Q)
$90.53B
Total Debt (Q)
$60.47B
Total Liabilities (Q)
$82.88B
Book Value Per Share (Q)
$14.31
Cash Flow
Cash from Operations (TTM)
$10.58B
Cash from Investing (TTM)
-$2.59B
Cash from Financing (TTM)
$17.25B
Net Change in Cash (TTM)
$25.24B
Filings
Filing Date
Tuesday, October 31, 2023
Period Date
Saturday, September 30, 2023
Next Filing
Week of Feb 5 and 9 (est)
Price History
Loading...
Beta
0.28
7-Day Total Return
0.95%
30-Day Total Return
0.57%
60-Day Total Return
3.41%
90-Day Total Return
18.68%
Year to Date Total Return
6.42%
1-Year Total Return
-2.49%
2-Year Total Return
34.52%
3-Year Total Return
29.35%
5-Year Total Return
61.57%
52-week Low
Jun 01, 2023 - $211.71
52-week High
Oct 13, 2023 - $288.46
Valuation
Market Cap
$145.20B - Large Cap
Enterprise Value
$170.93B
Price/Sales (TTM)
5.44
Price/Book (Q)
18.96
Dividends and Shares
Shares Outstanding
538.00M
Dividend Per Share (Most Recent)
$2.13
Dividend Per Share (TTM)
$8.52
Corporate Info
Website
www.amgen.com
Phone Number
805 447 1000
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Country
United States
Year Founded
1980
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and... more
NASDAQ 12/08/2023 4:00PM Eastern Quotes delayed
Weiss Ratings